BillionaireNet
Halbert
D
Rank #1127
UNITED STATESHealthcareBiotech

David Dean Halbert

Net Worth
$3.609B
+2.36% (24h)
David Dean Halbert, a prominent figure in the healthcare industry, is the Chairman, Founder, and CEO of Caris Life Sciences, a pioneering precision medicine company. With a net worth of $3.3 billion, David has dedicated his career to revolutionizing cancer care through innovative molecular profiling. His wealth stems from his success in the Biotech sector, including his founding of AdvancePCS, a pharmacy benefits management company sold for $7.5 billion. Recognized for his entrepreneurial achievements and commitment to precision medicine, Halbert's leadership has made a significant impact on improving patient care and advancing medical research. He has been awarded with an honorary Doctorate of Science for his philanthropic work and contributions to precision medicine.

The Full Dossier

Early Life

David Dean Halbert was born in Abilene, Texas, in 1956. Growing up in a family with a strong medical background, his father was a physician, he developed an early interest in business. His grandfather was also in the oil business, and Halbert's ambitions to make it big in the business world started at a young age. He attended Abilene Christian University, graduating with a Bachelor of Business Administration in 1978.

Rise to Success

Halbert's career began in the pharmacy benefits management industry. He founded AdvancePCS in 1987, which quickly grew to become the largest pharmacy benefit manager, serving over 75 million people. He served as Chairman and CEO of the company until it was sold to Caremark in 2004 for $7.5 billion. Following the sale of AdvancePCS, Halbert formed Caris Capital in 2005. In 2008, Halbert acquired Molecular Profiling Institute (MPI), an early-stage life sciences company. MPI was later renamed Caris Life Sciences. Caris Life Sciences has become a leader in molecular science and artificial intelligence, helping over half a million patients worldwide in their battle with cancer.

Key Business Strategies

Halbert's success stems from his ability to identify and capitalize on emerging trends in healthcare. At AdvancePCS, he focused on advancing quality of care while lowering healthcare costs. At Caris Life Sciences, he has pioneered a new era in precision medicine, using sophisticated disease profiling technologies to improve patient outcomes.

Philanthropy

Halbert and his family established the Caris Foundation in 2002, a non-profit that supports impoverished communities by helping to provide for their basic needs. In 2014, the Halberts donated $15 million to Abilene Christian University through the Caris Foundation. In 2017, the Caris Foundation was appointed to lead a $98.5 million investment by USAID to bolster Haiti's health system.

Career Timeline

2024

Awarded Honorary Doctorate

Received an honorary doctorate from Abilene Christian University.

2025

Caris Life Sciences IPO

Caris Life Sciences went public, making Halbert a billionaire.

2008

Acquired Molecular Profiling Institute (MPI)

Acquired the company that would become Caris Life Sciences.

2005

Formed Caris Capital

Began an investment firm.

2004

Sold AdvancePCS to Caremark

Sold AdvancePCS for $7.5 billion.

1987

Founded AdvancePCS

Founded pharmacy benefit management company, which became a leading company in the industry.

Philanthropic Impact

HealthcareUndisclosed

Caris Foundation

Supports impoverished people by providing for their basic needs in Africa and Haiti.

Education$15M

ACU Donations

Donation to Abilene Christian University for science building and stadium.

HealthcareUndisclosed

Project Santé

Led a $98.5 million investment by USAID to support Haiti's health system.

Wealth Trajectory